|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C12P 21/06 | |
| A61K 38/48 |
| (11) | Patento numeris | 3137621 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 15721027.9 |
| Europos patento paraiškos padavimo data | 2015-04-29 | |
| (97) | Europos patento paraiškos paskelbimo data | 2017-03-08 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2019-07-17 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/GB2015/051250 |
| Data | 2015-04-29 |
| (87) | Numeris | WO 2015/166242 |
| Data | 2015-11-05 |
| (30) | Numeris | Data | Šalis |
| 201407525 | 2014-04-29 | GB |
| (72) |
PALAN, Shilpa, GB
LIU, Sai Man, GB
HACKETT, Gavin Stephen, GB
|
| (73) |
Ipsen Bioinnovation Limited,
102 Park Drive Milton Park, Abingdon, Oxfordshire OX14 4RY,
GB
|
| (54) | MANUFACTURE OF RECOMBINANT CLOSTRIDIUM BOTULINUM NEUROTOXINS |
| MANUFACTURE OF RECOMBINANT CLOSTRIDIUM BOTULINUM NEUROTOXINS |